Drug Profile
Research programme: TNF inhibitors - e-Therapeutics
Alternative Names: ETS3100Latest Information Update: 28 Jul 2019
Price :
$50
*
At a glance
- Originator e-Therapeutics
- Class Small molecules
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 28 Jul 2019 No recent reports of development identified for preclinical development in Inflammation in United Kingdom
- 11 Jun 2015 Preclinical trials in Inflammation in United Kingdom (unspecified route)